Apollo Global Management agreed to buy easyJet plc for £5.7 billion on 6 August 2026. Target shareholders will receive £7.15 per share in cash. Chief executive Kenton Jarvis told Bloomberg News on 8 October 2026 that the transaction remains on...
Apple Inc. has named internal corporate development veteran Steve Smith as the new head of mergers and acquisitions, an appointment announced via an internal corporate memo circulated by Senior Vice President of Services Eddy Cue. According to...
Switzerland-based Partners Group Holding AG is liquidating its Guernsey-domiciled closed-ended investment company, Partners Group Private Equity Limited, following a shareholder vote on 7 October 2026. The London Stock Exchange-listed vehicle,...
Nvidia Corporation executed a technology licensing and talent transfer arrangement with artificial intelligence hardware developer Groq, Inc. on December 24, 2025 . Former Groq, Inc. engineers Benjamin Serebrin and Joshua Rubin filed a verified...
On October 7, 2026, Canadian holding company Wittington Investments, Limited agreed to purchase The Boots Group from majority owner Sycamore Partners and minority shareholder Stefano Pessina for $8.9 billion. The transaction transfers control of...
BlackRock entered an agreement on October 13, 2026, to acquire the majority equity stake in a primary care joint venture from Welsh, Carson, Anderson & Stowe for $2.8 billion. The transaction establishes a new partnership structure for Humana,...
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release published on the same day. The buyer plans to extract...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes a 44.8 percent premium over the closing price of...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the outstanding shares of the Austin, Texas-based...
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a contract manufacturing organization producing...